Trial of Screening for ALOA-IgG AtheroAbzyme Test
NCT01272986
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Myocardial Ischemia
Acute Coronary Syndrome
Interventions
DEVICE:
ALOA IgG-Elisa
DEVICE:
ALOA IgG-AtheroAbzyme
Sponsor
Omicron Pharmaceuticals